Shawn T Carolan Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 11 hours ago
Shawn T Carolan has an estimated net worth of at least $19.8 million*, as of yesterday. They own 18,381 shares of CHYM stock. They have sold 579,313 shares of CHYM stock since 2021, for an estimated $19.2 million.
Shawn T Carolan $CHYM SEC Form 4 Insider Trading
Shawn T Carolan has filed a total of 6 insider trades in $CHYM since 2021. Their most recent trade was a sale of 297,318 shares, made on Sep 10, 2026. Their largest trade was a sale of 297,318 shares, made on Sep 10, 2026. We estimate that they now own 18,381 shares of $CHYM, worth an estimated $597,842.
Insider Trading at $CHYM
There have been a total of 337 insider trades reported at $CHYM since 2021, with 2,250 shares purchased and 35.7 million shares sold. The most active insider traders in $CHYM stock have been Christopher R Britt, Adam B Frankel, and Amine Asmerom. The most recent trade was a sale of 1.4 million shares reported by Global Advisors Ltd DST (None), made on Sep 14, 2026.
History of Insider Stock Trades by Shawn T Carolan
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CHYM
|
Sale | 297,318 | Sep 10, 2026 | Sept. 15, 2026, 8:11 a.m. |
|
CHYM
|
Sale | 3,023 | Sep 10, 2026 | Sept. 15, 2026, 8:11 a.m. |
|
CHYM
|
Sale | 1,965 | Sep 10, 2026 | Sept. 15, 2026, 8:11 a.m. |
|
CHYM
|
Sale | 272,437 | Sep 11, 2026 | Sept. 15, 2026, 8:11 a.m. |
|
CHYM
|
Sale | 2,770 | Sep 11, 2026 | Sept. 15, 2026, 8:11 a.m. |
|
CHYM
|
Sale | 1,800 | Sep 11, 2026 | Sept. 15, 2026, 8:11 a.m. |
$CHYM Executives and Stock Owners with Insider Trades
-
Christopher R Britt, Chief Executive Officer
-
Adam B Frankel, General Counsel
-
Amine Asmerom, Chief Accounting Officer
-
Ryan A King, Co-Founder
-
Matthew S Newcomb, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.